Ankylosing Spondylitis
Conditions
Keywords
ankylosing spondylitis, aerobic exercise
Brief summary
This is a randomized controlled trial with blinded assessor on the effects of aerobic exercise (walking)in patients with Ankylosing Spondylitis.
Detailed description
Ankylosing Spondylitis (AS) is a systemic inflammatory disease that affects mainly the spine and compromises globally the physical capacity of the patients. Despite new advances in pharmacological therapy, physiotherapy and exercise remain essential in the treatment of AS. However, the literature lacks studies showing which types of exercises are more effective in patients with AS. This is a randomized controlled trial with the objective is to evaluate the effects of aerobic training on functional capacity, mobility, disease activity, cardiopulmonary capacity and cytokine levels (TNF, IL10, IL6 and IL1) in patients with AS. The duration of the trial is 24 weeks with the first 12 weeks reserved to exercise programs. The participants will be divided in two groups. The intervention group (IG) will perform walking for 50 minutes plus global stretching 3 times a week for 12 weeks. The control group (CG) will do only stretching exercises 3 times a week for 12 weeks.
Interventions
OTHERaerobic training
The intervention comprises fifty minutes of walking at anaerobic threshold plus stretching exercises 3 times a week for 12 weeks.
OTHERStretching exercises
Global stretching exercises will be performed for about 20 minutes 3 times a week for 12 weeks with supervision of specialized physiotherapists.
Sponsors
Fundação de Amparo à Pesquisa do Estado de São Paulo
Federal University of São Paulo
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* Diagnosis of Ankylosing Spondylitis according to New York modified criteria. * Stable drug treatment for at least 3 months * Sedentary for at least 3 months before randomization * Steinbrocker class I/II
Exclusion criteria
* Uncontrolled Systemic Arterial Hypertension and Diabetes mellitus. * Ischemic heart disease * Clinically significant diseases * Orthopedic surgery, such as hip arthroplasty, in the last year. * Inability to walk.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in BASFI | Baseline, after 6, 12 and 24 weeks. | Bath Ankylosing Spondylitis Functional Index (BASFI) is a quaestionnaire with 10 questions about functional capacity validated to AS patients. Each question is answered with a visual analogue scale 0-10 cm. Zero means the best, and 10 the worst function. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in BASMI | Baseline, after 6, 12 and 24 weeks. | Bath Ankylosing Spondylitis Mobility Index (BASMI) is an instrument that comprises 5 measures of mobility validated to AS patients. The measurements are: cervical rotation, lumbar flexion (Schober's test modified, intermalleolar distance, lumbar side flexion and tragus to wall. The total score is shown in a 0-10 cm visual analogue scale. The low scores represent better mobility. |
| Change in HAQ-S | Baseline, after 6, 12 and 24 weeks. | Health Assessment Questionnaire for Spondyloarthritis (HAQ-S)is a questionnaire with 10 domains about functional capacity validated to AS patients. The scores ranges from 0 to 3. |
| Incremental cardiopulmonary exercise testing protocol by treadmill | Baseline and after 12 weeks. | Incremental cardiopulmonary exercise testing protocol by treadmill is used to measure aerobic capacity of the patients. |
| Change in BASDAI | Baseline, after 6, 12 and 24 weeks. | Bath Ankylosing Spondylitis Disease Activity Score (BASDAI) is a instrument with 6 questions about disease activity validated to AS patients. The questions comprise the following areas: back pain, peripheral pain, morning stifness, fatigue and enthesitis. |
| Levels of cytokines- TNF, IL10, IL6 and IL1. | Baseline and after 12 weeks. | Cytokines are substances that make part of inflammatory response. The most important cytokines- TNF alpha, IL10, IL6 and IL1 will be measured in serum samples. |
| Change in the Six minute walking test | Baseline, after 6, 12 and 24 weeks. | The 6-minute walking test is a instrument to evaluate functional capacity. It is performed measuring the distance that the participant is able to walk during 6 minutes. |
| Levels of C reactive protein and erythrocyte rate sedimentation | Baseline, after 6. 12 and 24 weeks | CRP and ESR are laboratory methods to evaluate inflammatory response using blood sample. |
Countries
Brazil
Outcome results
None listed